Emerging therapies for metabolic diseases—the focus is on diabetes and obesity
Author:
Publisher
Elsevier BV
Subject
Biochemistry,Analytical Chemistry
Reference54 articles.
1. DPP-4 inhibitor therapy: new directions in the treatment of type 2 diabetes;Deacon;Front Biosci,2008
2. Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes;Ahrén;Expert Opin Emerg Drugs,2008
3. Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: a 54-week study;Williams-Herman;Curr Med Res Opin,2009
4. Efficacy and tolerability of initial combination therapy with vildagliptin and pioglitazone compared with component monotherapy in patients with type 2 diabetes;Rosenstock;Diabetes Obes Metab,2007
5. Mathematical modeling shows exenatide improved beta-cell function in patients with type 2 diabetes treated with metformin or metformin and a sulfonylurea;Mari;Horm Metab Res,2006
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Niazirin from Moringa oleifera Lam. attenuates high glucose-induced oxidative stress through PKCζ/Nox4 pathway;Phytomedicine;2021-06
2. Antiobesity effects of lycii fructus in high-fat diet/fructose-induced obese rats;Pharmacognosy Magazine;2020
3. Swertiamarin decreases lipid accumulation dependent on 3-ketoacyl-coA thiolase;Biomedicine & Pharmacotherapy;2019-04
4. Identification of Novel, Structurally Diverse, Small Molecule Modulators of GPR119;ASSAY and Drug Development Technologies;2018-07
5. LQTA-R: A new 3D-QSAR methodology applied to a set of DGAT1 inhibitors;Computational Biology and Chemistry;2018-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3